These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 9974369

  • 21. Hemostatic activation under anticoagulant treatment: a comparison of unfractionated heparin vs. nadroparin in the treatment of proximal deep vein thrombosis.
    Stricker H, Marchetti O, Haeberli A, Mombelli G.
    Thromb Haemost; 1999 Oct; 82(4):1227-31. PubMed ID: 10544903
    [Abstract] [Full Text] [Related]

  • 22. Treatment of deep vein thrombosis with continuous intravenous infusion of LMWH in children--an alternative to subcutaneous application when needed.
    Blatný J, Fiamoli V.
    Vnitr Lek; 2009 Mar; 55(3):227-32. PubMed ID: 19378852
    [Abstract] [Full Text] [Related]

  • 23. Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial.
    Mismetti P, Mille D, Laporte S, Charlet V, Buchmüller-Cordier A, Jacquin JP, Fournel P, Dutrey-Dupagne C, Decousus H, CIP Study Group.
    Haematologica; 2003 Jan; 88(1):67-73. PubMed ID: 12551829
    [Abstract] [Full Text] [Related]

  • 24. Isolated distal deep vein thrombosis: efficacy and safety of a protocol of treatment. Treatment of Isolated Calf Thrombosis (TICT) Study.
    Parisi R, Visonà A, Camporese G, Verlato F, Lessiani G, Antignani PL, Palareti G.
    Int Angiol; 2009 Feb; 28(1):68-72. PubMed ID: 19190559
    [Abstract] [Full Text] [Related]

  • 25. Home therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrations.
    Bellosta R, Ferrari P, Luzzani L, Carugati C, Cossu L, Talarico M, Sarcina A.
    Angiology; 2007 Feb; 58(3):316-22. PubMed ID: 17626986
    [Abstract] [Full Text] [Related]

  • 26. [Prevention of thrombosis in gynecology: double-blind comparison of low molecular weight heparin and unfractionated heparin].
    Heilmann L, Kruck M, Schindler AE.
    Geburtshilfe Frauenheilkd; 1989 Sep; 49(9):803-7. PubMed ID: 2553528
    [Abstract] [Full Text] [Related]

  • 27. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.
    Ramacciotti E, Araújo GR, Lastoria S, Maffei FH, Karaoglan de Moura L, Michaelis W, Sandri JL, Dietrich-Neto F, CLETRAT Investigators.
    Thromb Res; 2004 Sep; 114(3):149-53. PubMed ID: 15342210
    [Abstract] [Full Text] [Related]

  • 28. [Secondary prevention after deep venous thrombosis. Low molecular weight heparin versus coumarin].
    Hamann H.
    Zentralbl Chir; 1999 Sep; 124(1):24-6. PubMed ID: 10091293
    [Abstract] [Full Text] [Related]

  • 29. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS.
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [Abstract] [Full Text] [Related]

  • 30. Pharmacodynamics and tolerance of two nadroparin formulations (10,250 and 20,500 anti Xa IU x ml(-1)) delivered for 10 days at therapeutic dose.
    Boneu B, Navarro C, Cambus JP, Caplain H, d'Azemar P, Necciari J, Duret JP, Gaud C, Sié P.
    Thromb Haemost; 1998 Feb; 79(2):338-41. PubMed ID: 9493587
    [Abstract] [Full Text] [Related]

  • 31. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S, Breyer HG, Bacher HP, Fareed J, Misselwitz F, Victor N, Weber J, ECHOS Trial Group.
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [Abstract] [Full Text] [Related]

  • 32. Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis.
    Belcaro G, Nicolaides AN, Cesarone MR, Laurora G, De Sanctis MT, Incandela L, Barsotti A, Corsi M, Vasdekis S, Christopoulos D, Lennox A, Malouf M.
    Angiology; 1999 Oct; 50(10):781-7. PubMed ID: 10535716
    [Abstract] [Full Text] [Related]

  • 33. Effects of standard unfractionated and low-molecular-weight heparins on platelets of patients undergoing total hip replacement surgery.
    Aulmann M, Kwasniki S, Böttiger BW, Meeder PJ.
    Beitr Infusionsther Transfusionsmed; 1997 Oct; 34():242-7. PubMed ID: 9356680
    [Abstract] [Full Text] [Related]

  • 34. Low molecular weight heparin (Alfa LHWH) compared with unfractionated heparin in prevention of deep-vein thrombosis after hip fractures.
    Pini M, Tagliaferri A, Manotti C, Lasagni F, Rinaldi E, Dettori AG.
    Int Angiol; 1989 Oct; 8(3):134-9. PubMed ID: 2556484
    [Abstract] [Full Text] [Related]

  • 35. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism.
    Prandoni P, Carnovali M, Marchiori A, Galilei Investigators.
    Arch Intern Med; 2004 May 24; 164(10):1077-83. PubMed ID: 15159264
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
    Kirchmaier CM, Wolf H, Schäfer H, Ehlers B, Breddin HK.
    Int Angiol; 1998 Sep 24; 17(3):135-45. PubMed ID: 9821025
    [Abstract] [Full Text] [Related]

  • 37. [Low molecular weight heparin versus unfractionated heparin in the treatment of deep venous thrombosis--a meta-analysis].
    Nielsen JD, Landorph A.
    Ugeskr Laeger; 1994 Oct 03; 156(40):5844-9. PubMed ID: 7985276
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis.
    Brandjes DP, Heijboer H, Büller HR, de Rijk M, Jagt H, ten Cate JW.
    N Engl J Med; 1992 Nov 19; 327(21):1485-9. PubMed ID: 1406880
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.